Omada Health, Inc.

OMDA

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
OMDA
CIK0001611115
SIC8000
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address500 SANSOME STREET, SUITE 200, SAN FRANCISCO, CA, 94111
Website www.omadahealth.com
Phone888-987-8337
CEOSean Duffy
Employees849

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Omada Health releases new data on its GLP-1 companion program

Omada Health (OMDA) released new data demonstrating that Omada’s GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss. Omada’s analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings. Omada analyzed 1,124 members without diabetes who self-reported GLP-1 use to assess the impa

Article Link

Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promisesSAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada’s GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with g

Article Link

Should You Buy JBS Stock After the Meat Giant’s IPO?

Activists and lawmakers have expressed concerns about JBS’s environmental practices.

Article Link

US IPO shares doubling on their first day at fastest pace since 2021

(Bloomberg) -- Stocks of newly-public companies are surging in their first sessions at the fastest pace in three and a half years, enthralling traders and heating up the market for US first-time share sales.Most Read from BloombergShuttered NY College Has Alumni Fighting Over Its FutureAs Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention SpaceAs American Architects Gather in Boston, Retrofits Are All the RageDrone maker Airo Group Holdings Inc. ended Friday with a gain o

Article Link

Revelation-Backed Omada Health Jumps After $150 Million IPO

(Bloomberg) -- Omada Health Inc. shares ended their debut trading day exactly where they started after the digital health-care company raised $150 million in its initial public offering.Most Read from BloombergNext Stop: Rancho Cucamonga!Where Public Transit Systems Are Bouncing Back Around the WorldICE Moves to DNA-Test Families Targeted for Deportation with New ContractUS Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents WarnTrump Said He Fired the National Portrait Gallery Directo

Article Link